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ABSTRACT
etabolic syndrome (MetS) is a cluster of 
multiple metabolic abnormalities that 
increase the risk of cardiovascular M
1morbidity and mortality.  The specific components of 
the syndrome include: central obesity, glucose 
intolerance, elevated triglycerides, low levels of high 
density lipoprotein cholesterol (HDL-C) and 
2hypertension.  The presence  of the MetS is associated 
with an approximate doubling of the risk of 
3cardiovascular diseases (CVD) and mortality.  The 
cardinal abnormality in metabolic syndrome is central 
obesity, which in itself increases the risk of insulin 
resistance.
The epidemiological significance of the MetS as a tool 
for identifying individuals at high risk for 
cardiovascular disease coupled with its rising 
prevalence worldwide has lead to wide interest in the 
condition by several expert groups resulting in 
different diagnostic definitions for the syndrome. 
In 2005 the American Heart Association and the 
National  Heart  Lung and Blood Inst i tute  
(AHA/NHLBI)  and the International Diabetes 
Federation (IDF) published  criteria for the metabolic 
syndrome designed to be of practical application in 
4,5epidemiological studies.  The AHA/NHLBI criteria 
were essentially a revision of the 2001 National 
Cholesterol Education Programme (NCEP) Adult 
6Treatment Panel III  (ATP III) criteria.  Both the IDF and 
the revised ATP III used the five components 
mentioned above but differed in that the IDF criteria 
regarded central obesity as a required component with 
the diagnosis being made if any two of the other 
components were present, while the revised ATP III 
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PREVALENCE OF METABOLIC SYNDROME AMONG 
APPARENTLY HEALTHY ADULTS IN A RURAL COMMUNITY, 
IN NORTH-WESTERN NIGERIA.
BACKGROUND
Metabolic syndrome (MetS) is a cluster of multiple metabolic abnormalities that increases the risk of cardiovascular 
morbidity and mortality, and a resultant severe economic implication. This study assessed the burden of MetS in a 
Nigerian rural community setting.
METHOD
This was a cross-sectional, community based study on apparently healthy subjects. A multi stage cluster sampling 
technique was employed to recruit the study subjects. A standardized pre-tested questionnaire was used to obtain 
data, and blood samples from subjects were analysed using standard laboratory techniques. MetS was defined using 
the NCEP-ATP3 criteria. Data were analysed using STATA version 11, and a p value of <0.05 was considered 
statistically significant.
RESULTS
A total of 450 subjects completed the study, with 38% being males, and a mean age of 40.27±16.41 years. MetS was 
found in 116 (25.78%) of the subjects. Of these, systemic hypertension was found in 91(78.45%), while all (116) had 
elevated cholesterol and triglycerides. Abdominal adiposity  was found in 45 (38.79%) subjects and 44 (37.93%) had 
Type 2 diabetes mellitus.
CONCLUSION
The prevalence of MetS and its components in our studied population was high; hence the need for further large 
population based studies to determine its predictors in our environment.
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We recruited subjects who gave informed consent to 
participate in the study after adequate information on 
the study objectives and its potential benefit to the 
participants and community. Ethical approvals were 
obtained from the research and ethics committee of 
Aminu Kano Teaching Hospital Kano, and Kumbotso 
local government council before the commencement of 
the study. Six out of twelve political wards were 
selected randomly by balloting. A multistage cluster 
sampling was used. One settlement was randomly 
selected from the list of all settlements in each ward. 
Households in each of the settlement were then 
selected systematically, using a sample interval. All 
persons aged 18 years and above in each selected 
household were recruited until sample size of 500 
subjects was obtained. Participants with comorbidity 
e.g. hypertension, renal disease and diabetes mellitus 
were excluded. 
Subject's biodata were obtained using a standardized 
questionnaire. The anthropometric parameters of the 
subjects were measured using standard techniques. 
The height and weight of each subject was measured to 
the nearest 0.1m and 0.1kg respectively. The body  
16  mass index (BMI) was calculated using the Quetelet's 
2index ; BMI= Weight (kg) / height (m)   Waist 
circumference was measured to the nearest 0.5cm on 
bare skin of an erect  subject using  a non-stretchable 
thtape measure with landmarks as mid-point of the 10  
rib and iliac crest (at approximate level with the 
umbilicus in a horizontal plane). Two independent 
measurements were done by two assessors and the 
average taken. The Waist-hip ratio was taken in all 
subjects.
The blood pressure was measured at two different 
times at least 30mins apart, using the right arm to the 
nearest 2mmHg with subjects sitting on a chair beside a 
consulting table after at least 5 minutes rest using 
standard mercury sphygmomanometer. Using a 
prominent ante-cubetal vein after observance of 
appropriate asepsis, 10ml of venous blood was drawn 
for fasting plasma glucose and serum lipids with 5ml 
each dispensed into appropriate specimen bottles 
stored in ice packs and subsequently transported to the 
chemical pathology laboratory within 2 hours for 
17analysis. The glucose oxidase method of Trinder  was 
used to analyse plasma glucose while the serum total 
cholesterol, high density lipoprotein (HDL), 
triglycerides (TG) were analysed  using relevant assay 
techniques. The serum low density lipoprotein (LDL) 
cholesterol was calculated for each subject using the 
18Friedwald's  equation with the exception of samples in 
which TG is more than 400mg/dl (in which case LDL 
was measured directly).  We confirmed the presence of 
the metabolic syndrome in a subject if he / she fulfilled 
6the criteria defined by the NCEP-ATP III.
Recently, in conjunction with representatives from the 
World Heart Federation, International Atherosclerosis 
Society, and International Association for the Study of 
Obesity, a revised set of criteria harmonizing the 
7definition of MetS were published.  The prevalence of 
MetS varies between different populations. In 
developed countries MetS  is estimated to affect around 
825% of the population.  The prevalence of MetS tends to 
be even higher when cohorts  of subjects already 
having cardiovascular risks such as hypertension or 
diabetes are evaluated as was demonstrated in 
Caucasians with type 2 diabetes where the prevalence 
9was 75.6%.
Diabetes Mellitus (DM) as an important component of 
the MetS has assumed epidemic proportion with a total 
global prevalence of 371 million in the year 2012 and a 
10projected rise to 552 million by the year 2030.  It is of 
note that the majority of this increase, which is expected 
to be of the type 2 DM, is being envisaged to occur in 
10 developing countries. This may be due to advancing 
age, physical inactivity, unhealthy diet, ever increasing 
incidence of overweight and obesity engendered by 
rapid urbanization and westernization in the African 
10 countries.
The MetS has severe economic implications, with 
estimates that the related condition, (obesity) leading to 
health costs of about $100 billion yearly in the United 
6States.  This is frightening as such economic burden 
11cannot be borne by most developing nations.
12Studies on MetS in sub-Saharan Africa are scanty.  
Previous studies in Nigeria have reported prevalence 
rates of MetS of up to 80% among persons with                 
13, 14diabetes mellitus .  Most of these studies were 
however, carried out mainly in urban populations. A 
study among rural dwellers in Southwestern Nigeria 
15revealed a prevalence of MetS of 12.1%.  There is 
paucity of data on the prevalence of MetS among rural 
dwellers in Northern Nigeria. No such study has been 
conducted in Kano, northwestern Nigeria. In this 
study, we aimed to determine the prevalence of MetS 
among apparently healthy adults resident in a rural 
community using the NCEP-ATP III criteria.
METHODS
The study was a community-based cross-sectional 
evaluation of metabolic syndrome of apparently 
healthy individuals living in a rural area (Kumbotso 
local government area) of Kano state, north-west 
Nigeria. Kumbotso is a rural community with a mixed 
population of farmers, traders, Islamic scholars and 
students. It has a primary health care centre and a 
general hospital with very limited number of health 
workers. 
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while 56 (12.4%) had hypertriglyceridemia. We found 
78(17.3%) persons having high waist circumference; 
while 67(14.89%) were diabetic. Figure 1
Among the study participants with metabolic 
syndrome, 91 (78.45%) had systemic hypertension; 
while all persons with metabolic syndrome 116 (100%) 
had high cholesterol. Equally, 116(100%) of them had 
high triglyceride levels. 45(38.79%) of them had high 
waist circumference, with 44 (37.93%) being diabetic. 
All variable mean measures were higher in persons 
with metabolic syndrome compared to those without. 
Furthermore, the differences were all statistically 
significant. Table 2
There is a positive correlation between waist 
circumference and cholesterol level (p <0.003) though 
with a weak association (Pearson correlation = 0.136). 
Similarly, there is a positive correlation between waist 
circumference and triglyceride level; (Pearson 
correlation= 0.11); it was significant at (p <0.02). Figure 
2.
Although on logistic regression model, being a female 
was associated with 15% higher risk of developing 
metabolic syndrome, the association was weak without 
a statistically significant association. Other variable 
were also not strongly associated with it.
Data analysis
Quantitative variables were summarized using mean, 
and standard deviation, or median and quartiles, as 
appropriate. Categorical variables were tabulated 
using frequencies and percentages. The differences in 
means were determined by t-test when normally 
distributed and by Mann Whitney test when non-
parametric. Data was analyzed  using STATA version 
11 (Stata Corporation, College Station, USA).  We 
considered p < 0.05 as attaining statistical significance. 
RESULTS
A total of 450 persons were enrolled. Of these, 171 
(38.0%) were males, with a mean±SD age of 
40.27±16.41years; 95% C.I. [38.75 - 41.79]. The 
prevalence of metSynd identified among the study 
population is 25.78%. the proportion females with 
metSynd was significantly higher (77.57%) than in 
males (22.43%), p <0.05. Those with metabolic 
syndrome have significantly higher age, Table 1. Of all 
studied persons, 129 (28.7%) were employed while 71.3 
% are unemployed. Furthermore, 330 (73.3%) were 
m a r r i e d  w i t h  2 6 . 7  w e r e  e i t h e r  s i n g l e  
divorced/widowed. There is also a significant 
difference in marital and occupational status between 
those with and without metabolic syndrome. Table 1.
Of the study participants, 292(54.2%) had systemic 
hypertension; 116(25.8%) had hypercholesterolemia; 
Table 1. Demographic characteristics of Study population















Mean (SD)  
WC (cm) 81.25 (±11.15)    88.84 (±12.95) 78.61  (±9.10) 0.0001 
BMI (Kg/m2) 23.78 (±5.09) 27.15  (±6.39) 22.61 (±3.94) 0.0001 
TG (mg/dl) 88.082(±49.87)  110.54(±58.66) 80.28 (±43.92) 0.0001 
HDL-c (mg/dl) 167.76(±45.27)  187.69 (±47.42) 161.34 
(±41.58) 
0.0001 
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Table 2. Components of the metabolic syndrome among persons with and without Metabolic syndrome.
WC = Waist Circumference; BMI = Body Mass Index; TG = Triglycerides; 
HDL-c = High Density Lipoprotein Cholesterol; FPG = Fasting Plasma Glucose
Table 3. Logistic regression modeling for determining predictors of metabolic  syndrome     
BMI = Body Mass index; FPG = Fasting Blood Sugar
Figure 1.Prevalence of cardiovascular risk factors among study population by gender 
(Height represent percentages)
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workers have however, reported higher prevalence of 
13, 14, 27 MetS among men than women. Both elevated 
triglycerides and reduced HDL were found in 100% of 
our subjects with MetS. Hypertriglyceridaemia and 
low HDL are the two main types of dyslipidaemia 
14associated with MetS. Puepet et al  also reported high 
rate of hypertriglyceridaemia among their subjects 
w i t h  M e t S .  O t h e r  s t u d i e s  d i d  n o t  f i n d  
hypertriglyceridaemia to be a significant contributor to 
15, 28-30dyslipidaemia among subjects with MetS.  Low 
HDL has been reported to be highly prevalent among 
persons with MetS in studies from Nigeria and 
31-33Bostwana.
Hypertension was the second most common 
component of MetS identified in this study with a 
prevalence of 78.5%. Hypertension is one of the most 
20, 32,34 common cardiovascular disorders in Africa today.  
In a Nigerian national survey reported in 1997, Kano 
State had the highest prevalence of hypertension in the 
35country.  In a recent Nigerian multicentre study of 535 
36 diabetics by Uloko et al, the prevalence of 
hypertension was found to be 60.9% with a large 
proportion of the patients having  abnormal 
anthropometric indices (especially central obesity), 
atherogenic dyslipidaemia and markers of insulin 
resistance. With the prevailing epidemiologic 
DISCUSSION
The Metabolic syndrome (MetS) is a cluster of risk 
factors that predispose to cardiovascular disease 
19 (CVD) morbidity and mortality. These risk factors 
include obesity, dysglycaemia, dyslipidaemia and 
20 hypertension. The prevalence of MetS is increasing 
rapidly worldwide in parallel with the increasing 
21prevalence of type 2 diabetes and obesity.  In our 
study, we found the prevalence of MetS to be 25.8%, a 
figure that is higher than the 18.0% reported by Ulasi et 
22 23al , but lower than the 36.7% reported by Ghazali et al  
in an urban Nigerian population. The latter study was 
carried out in Ibadan, Southwest Nigeria. Regional 
differences in the prevalence of obesity (including 
24central adiposity) have been observed by Okafor et al  
in a multicenter study among urban dwelling 
Nigerians drawn from five geopolitical zones of the 
country with subjects from the South having higher 
rates of overweight and obesity than their Northern 
counterparts, a finding that may explain the higher 
prevalence of the MetS, considering the pivotal role of 
obesity in its pathogenesis.  The higher prevalence of 
MetS among women compared with men in the index 
study is in tandem with reports from studies done 
11, 25, 26 elsewhere. This observation has been attributed to 
higher rates of obesity and lower levels of physical 
activity among women compared with men. Other 
Figure 2.  Correlation between waist circumference, cholesterol and triglyceride levels
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